Miscellaneous Quiz / Multiple Sclerosis Agents

Random Miscellaneous Quiz

Can you name the Multiple Sclerosis Agents?

Quiz not verified by Sporcle

Forced Order
Also try: 'X' Alphabetically
Challenge
Share
Tweet
Embed
Score 0/68 Timer 20:00
HintAnswer
Carbamazepine class
SE: HR reduction of 10-20 bpm, occasionally bradyarrhythmias or AV block -- screen for cardiac dz (6 hr monitoring w/ first dose). Macular edema in 1% (reversible). Check varicella
Baclofen class
MOA: Monoclonal Ab. Shows functional improvement not just slowing of decline
Tricyclic class
Alemtizumab class
SE: Seizures at higher than recommended doses (contraindicated in pts with a hx of seizure)
Use: pain and paroxysmal disorders
Use: For pts who do not respond to corticosteroids during acute attacks
Off line agent used in the treatment of acute attacks
Glatiramer acetate class
Dose: SC injection every other day
Dose: SC injection 2-3 times weekly
Use: Depression. Also helps with fatigue
Use: Fatigue, cognitive impairment (long acting agent)
Dose: Oral. In extreme cases intrathecal
Dose: IM weekly
Axathioprine class
Fingolimod class
IFN beta 1-a (Rebif) class
Methylprednisone class
Second line agent for RRMS that produces reduction in progression of disabilty
Cyclophosphamide class
HintAnswer
MOA: Antimetabolite and antifolate
MOA: Potassium channel blocker. Possibly increases conduction in demyelinated axons
Use: Depression. Also helps with pain
First line drugs for disease modification
MOA: Synthetic form of myelin basic PRO copolymer 1. Binds to MHC molecules. Competes w/ myelin antigens for presentation to T cells.
Use: Fatigue
MOA: Immunomodulator/antineoplastic
MOA: Immune modulator, exact mechanism not known.
SE: Localized inj site reactions. Self-limited (15-20 min) acute rxn resembling a panic attack (palpitations, dyspnea, flushing) -- not an indication to stop tx
SE: Inj site rxn w/ high doses, flu-like s/s (responds well to naproxen), monitor liver fx, may develop neutralizing Ab, may increase depression.
SE: Risk of progressive multifocal leukoencephalopathy. Rare fatal viral (polymyxoma JC virus) reactivation infxn affecting white matter in immunosuppressed (only a risk to pts w/
IFN beta 1-a (Avonex) class
Second line agent MOA: monoclonal Ab
Second line agent given IV monthy
Excreted by kidney: contraindicated in moderate to severe renal failure
MOA: alkylating agent
MOA: Purine analog
MOA: Sphingosine 1-phosphate receptor modulator. Sequesters lymphocytes.
Mycophenolate class
Prednisone class
Methotrexate class
Duloxetine class
IFN beta 1-b (Betaseron) class
HintAnswer
SE: Thyroid disorders, ITP (with fatal brain hemorrhage), infections.
MOA: Anti-organ rejection drug
Dose: 1 gram/day IV for 3-5 days
Dose: Oral daily (first PO MS drug)
Dose: IV infusion every 3 months
Gabapentin class
Rituximab class
Modafinil class
Methylphenidate class
Second line agent: RRMS, SPMS, Progressive Relapsing MS
Dalfampridine class
Plasmapheresis class
Natalizumab class
Second line agent: RRMS. Reduced relapses & progression of disability
First line RRMS agent injected SC daily
Mitoxantrone class
Use: treatment of spasticity
Bupropion class
Dose: 1250 mg/day PO for 3-5 days
Daclizumab class
Venlafaxine class
Tizanidine class

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras

Top Quizzes Today


Score Distribution

Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.